Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03804853 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rehabilitation Following Reverse Total Shoulder Arthroplasty

Study acronym: RTSA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Completion date: Dec 31, 2026 to Jun 30, 2027v10
  2. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2026v9
  3. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2025v8
  4. Primary and study completion dates: Dec 31, 2022 to Dec 31, 2024v7
  5. 2 versions Re-verified since Mar 24, 2021, no change to tracked fieldsv5-v6
Show 3 earlier versionsHide 3 earlier versions
  1. Primary and study completion dates: Dec 31, 2020 to Dec 31, 2022v4
  2. Re-verified, no change to tracked fieldsv3
  3. Phase: Early Phase 1 to Not applicable Secondary endpoints: details revised at 1 of 1 entryv2 Show 1 more changeShow less
    • Secondary endpoints: details revised at 1 of 1 entry
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Reverse total shoulder arthroplasty (RTSA) has been successful in patients with rotator cuff arthropathy, proximal humerus fractures, failed primary total shoulder arthroplasty or failed hemiarthroplasty, and massive irreparable rotator cuff tear. Patients who undergo an RTSA report pain relief and functional range of motion. It has been more than 20 years since the advent of the RTSA construct but an immediate post-operative rehabilitation with active shoulder range of motion has not been prospectively studied in comparison to the traditional post-operative rehabilitation highlighted by Boudreau et al.12 Investigators plan to prospectively follow our patients following RTSA undergoing an immediate active shoulder rehabilitation (IASR) vs traditional rehabilitation in a randomized controlled fashion. Investigators plan to document clinical outcomes, complications and cost effectiveness out to 1 year. The study will hopefully fulfill the Triple Aim model for HealthPartners by improving the health of the population, improve the experience of each individual, and make healthcare affordable by decreasing the total cost of care.
Trial Details
NCT Number NCT03804853
Lead Sponsor HealthPartners Institute
Collaborators: TRIA Orthopaedic Center
Conditions Shoulder Osteoarthritis
Enrollment 74 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov